171 related articles for article (PubMed ID: 33971493)
1. Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats.
Ali AA; Abd El-Fattah AI; Abu-Elfotuh K; Elariny HA
Int Immunopharmacol; 2021 Jul; 96():107729. PubMed ID: 33971493
[TBL] [Abstract][Full Text] [Related]
2. The influence of vinpocetine alone or in combination with Epigallocatechin-3-gallate, Coenzyme COQ10, Vitamin E and Selenium as a potential neuroprotective combination against aluminium-induced Alzheimer's disease in Wistar Albino Rats.
Ali AA; Khalil MG; Abd El-Latif DM; Okda T; Abdelaziz AI; Abu-Elfotuh K; Kamal MM; Wahid A
Arch Gerontol Geriatr; 2022; 98():104557. PubMed ID: 34706318
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine ameliorates Alzheimer's disease progression and prevents the exacerbation of cardiovascular dysfunction of socially isolated depressed rats through activation of Nrf2/HO-1 and hindering TLR4/NLRP3 inflammasome signaling pathway.
Abu-Elfotuh K; Al-Najjar AH; Mohammed AA; Aboutaleb AS; Badawi GA
Int Immunopharmacol; 2022 Mar; 104():108488. PubMed ID: 35042170
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects of vitamin E, acetyl-L-carnitine and α-lipoic acid on new potential biomarkers for Alzheimer's disease in rat model.
Ahmed HH
Exp Toxicol Pathol; 2012 Sep; 64(6):549-56. PubMed ID: 21183322
[TBL] [Abstract][Full Text] [Related]
6. The effects of eight weeks of aerobic training with vitamin C on the expression pathway of antioxidants in the hippocampus tissue of TMT induced Alzheimer's disease rats.
Hashemi SA; Ghadimi Z; Ghaedi H; Hashemi A
Brain Res; 2024 Jan; 1822():148645. PubMed ID: 37871672
[TBL] [Abstract][Full Text] [Related]
7. Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats.
Mahdy K; Shaker O; Wafay H; Nassar Y; Hassan H; Hussein A
Eur Rev Med Pharmacol Sci; 2012 Jul; 16 Suppl 3():31-42. PubMed ID: 22957416
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with the phenolics (-)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice.
Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
J Biol Chem; 2019 Feb; 294(8):2714-2731. PubMed ID: 30563837
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review.
Khalifa MKA; Abdel-Sattar SA; Amin OM; Kohaf NA; Zaky HS; Abd El-Fattah MA; Mohammed KHA; Badawi NM; Mansoor I; Eassa HA
Daru; 2024 Jun; 32(1):319-337. PubMed ID: 38079104
[TBL] [Abstract][Full Text] [Related]
10. [Effects of vitamin E and ω-3 fatty acids on protecting ambient PM_(2. 5)-induced cardiovascular injury].
Du X; Jiang S; Bo L; Liu J; Zeng X; Jiang R; Song W; Zhao J
Wei Sheng Yan Jiu; 2017 Jul; 46(4):517-537. PubMed ID: 29903169
[TBL] [Abstract][Full Text] [Related]
11. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.
Smith A; Giunta B; Bickford PC; Fountain M; Tan J; Shytle RD
Int J Pharm; 2010 Apr; 389(1-2):207-12. PubMed ID: 20083179
[TBL] [Abstract][Full Text] [Related]
12. Physical & mental activities enhance the neuroprotective effect of vinpocetine & coenzyme Q10 combination against Alzheimer & bone remodeling in rats.
Ali AA; Abo El-Ella DM; El-Emam SZ; Shahat AS; El-Sayed RM
Life Sci; 2019 Jul; 229():21-35. PubMed ID: 31063734
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.
Rasoolijazi H; Joghataie MT; Roghani M; Nobakht M
Iran Biomed J; 2007 Oct; 11(4):237-43. PubMed ID: 18392085
[TBL] [Abstract][Full Text] [Related]
14. Anti-Alzheimer Activity of Combinations of Cocoa with Vinpocetine or Other Nutraceuticals in Rat Model: Modulation of Wnt3/β-Catenin/GSK-3β/Nrf2/HO-1 and PERK/CHOP/Bcl-2 Pathways.
Abu-Elfotuh K; Tolba AMA; Hussein FH; Hamdan AME; Rabeh MA; Alshahri SA; Ali AA; Mosaad SM; Mahmoud NA; Elsaeed MY; Abdelglil RM; El-Awady RR; Galal ERM; Kamal MM; Elsisi AMM; Darwish A; Gowifel AMH; Mahran YF
Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631278
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Chen DD; Dong YG; Liu D; He JG
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
[TBL] [Abstract][Full Text] [Related]
16. Windows into estradiol effects in Alzheimer's disease therapy.
Mohamd EM; Ahmed HH; Estefan SF; Farrag AE; Salah RS
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1131-40. PubMed ID: 22165673
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.
Bao J; Liu W; Zhou HY; Gui YR; Yang YH; Wu MJ; Xiao YF; Shang JT; Long GF; Shu XJ
Curr Med Sci; 2020 Feb; 40(1):18-27. PubMed ID: 32166661
[TBL] [Abstract][Full Text] [Related]
18. Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate.
Xie Q; Cai X; Dong X; Wang Y; Sun M; Tai L; Xu Y
Pharm Biol; 2021 Dec; 59(1):157-166. PubMed ID: 33556300
[TBL] [Abstract][Full Text] [Related]
19. Corydalis edulis total alkaloids (CETA) ameliorates cognitive dysfunction in rat model of Alzheimer disease through regulation of the antioxidant stress and MAP2/NF-κB.
Liang S; Zheng Y; Lei L; Deng X; Ai J; Li Y; Zhang T; Mei Z; Ren Y
J Ethnopharmacol; 2020 Apr; 251():112540. PubMed ID: 31917278
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
Kim CY; Lee C; Park GH; Jang JH
Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
